Empowering Early Stage Biotech with Strategic R&D for Data-driven Funding Success
Key2Meds is an integrated drug R&D platform specializing in nanobody, peptide, and small molecule development
Solutions
Nanobody Discovery
Camelid nanobodies are much smaller and can be used in multiple contexts making them more versatile than monoclonal antibodies.
Biologics
Chemistry
Synthetic chemistry, focused on the design and synthesis of new molecules is crucial in discovering novel pharmaceuticals, enhancing efficacy, and reducing side effects.
Pharmacology
ADME-PK: Adsorption, Distribution, metabolism, excretion, and pharmacokinetics provides the pathway for a small molecules and biologics to the clinic.
Animal Models
Efficacy in CDx and PDx models are critical to ensuring your drug is on-target and active in vivo.
In vivo disease models
Peptide Discovery
Peptides can form the basis of a drug or may be able to direct your drug to a target cell in vivo.
Peptides
ADC Payload
A novel synthetic lethal payload can increase the specificity and reduce toxicity of ADCs.
